Satellos Bioscience

MSLE

Capitalización de mercado USD 137 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Franklin Resources San Mateo, California	USD 7.23 M	–	–	–
2	SL 2 Siren LLC Greenwich, Connecticut	USD 6.94 M	–	–	–
3	3 Vivo Capital Palo Alto, California	USD 6.33 M	–	–	–
4	4 Point72 Asset Management Stamford, Connecticut	USD 5.31 M	-USD 55.5 k	-8,078	-1%
5	5 Sphera Funds Management Tel Aviv, Israel	USD 5.07 M	+USD 1.12 M	+163,383	+33%
6	6 Woodline Partners San Francisco, California	USD 3.89 M	–	–	–
7	SCM 7 Stonepine Capital Management Bend, Oregon	USD 3.72 M	+USD 2.69 M	+391,624	+392%
8	SCM 8 Suvretta Capital Management New York	USD 3.69 M	–	–	–
9	APM 9 Avidity Partners Management Dallas, Texas	USD 3.01 M	–	–	–
10	SVCM 10 Saturn V Capital Management Austin, Texas	USD 2.72 M	–	–	–
11	11 Soleus Capital Management Greenwich, Connecticut	USD 2.44 M	-USD 687 k	-100,000	-24%
12	6CM 12 683 Capital Management New York	USD 1.79 M	–	–	–
13	13 ADAR1 Capital Management Austin, Texas	USD 1.73 M	–	–	–
14	AIC 14 AWM Investment Company New York	USD 1.4 M	+USD 1.24 M	+180,000	Nuevas
15	15 Millennium Management New York	USD 1.19 M	-USD 1 M	-145,665	-49%
16	16 Adage Capital Partners Boston, Massachusetts	USD 1.17 M	-USD 1.58 M	-230,354	-61%
17	EAM 17 Empery Asset Management New York	USD 833 k	-USD 845 k	-123,000	-53%
18	18 Citadel Advisors Miami, Florida	USD 527 k	+USD 173 k	+25,246	+59%
19	19 Morgan Stanley New York	USD 200 k	+USD 31.3 k	+4,549	+21%
20	20 China Universal Asset Management Company Shanghai, China	USD 156 k	+USD 93.4 k	+13,600	+213%
21	21 Royal Bank of Canada Toronto, Ontario, Canada	USD 124 k	-USD 2.62 k	-382	-2%
22	22 Geode Capital Management Boston, Massachusetts	USD 92.6 k	–	–	–
23	23 UBS Group Zurich, Switzerland	USD 6.07 k	+USD 5.17 k	+753	+2,689%
24	24 JP Morgan Chase New York	USD 2.48 k	+USD 2.16 k	+315	Nuevas
25	25 Federation des caisses Desjardins du Quebec Levis, Quebec, Canada	USD 143	–	–	–

Satellos Bioscience MSLE Capitalización de mercado USD 137 M

Satellos Bioscience

MSLE

Capitalización de mercado USD 137 M